Will Donald Trump Make Friends With Big Pharma Or Keep His Election Promise?

Donald Trump meeting with senior drug company executives in the Oval Office at the White House, 31 January, 2017.
Image: @POTUS via twitter.com

By Paul Anthony Taylor

In a meeting held in the Oval Office on January 31, however, the new president took a somewhat different approach and assured an assembled group of senior drug company executives that they had “done a terrific job over the years.” In return for bringing drug production back to the U.S., Trump told them, his administration would reduce regulations affecting pharma companies and lower their taxes. Predictably, stock prices of most of the firms present subsequently soared.

For a man said to be opposed to Big Pharma, the impression Trump gave in this Oval Office meeting was that he would do everything possible to help it. Openly stating that U.S. drug companies have produced “extraordinary results” for the country, he said his administration’s focus would be on “accelerating cures” and making the drug approval process “much faster.”

During the meeting, Trump went to great lengths to assure drug executives he would “get rid of a tremendous number of regulations” affecting their industry. These would be cut, he said, “at a level that nobody’s ever seen before.” Promising them they would “do great” under his administration, he committed to lowering pharma taxes “big league.”

Clearly warmed by Trump’s words, the drug industry executives seated around the table talked enthusiastically about “cancer cures” and eradicating diseases, saying that reducing regulations and lowering taxes would really help them.

But let’s not be fooled here. While the media headlines for this story centered around Trump’s supposed goal of lowering drug prices, the fact is that pharmaceutical companies will not go along with anything that would negatively affect their profits. As components of a trillion-dollar-a-year industry, drug corporations will not tolerate a dramatic mass lowering of their prices. If threatened, they will use their army of media supporters, lobbyists, and politicians to destroy anyone undermining their economic power.

True solutions to health can’t be built on enforcing the status quo and its outdated approaches that, time and again, have already proven ineffective.

True solutions to health can’t be built on enforcing the status quo and its outdated approaches that, time and again, have already proven ineffective. Trump’s focus should therefore shift towards addressing the primary cause of chronic diseases – micronutrient deficiencies – and to building a prevention-oriented and effective-based system of medicine. This means medicine that does not merely mask symptoms, but eradicates diseases by eliminating their root causes. Only nutritional and Cellular Medicine approaches can assure that diseases can truly be eradicated.

However, if the Trump administration does nothing in this area, diseases will continue and expand – thus assuring that the drug industry will not only survive, but thrive. Access to effective and affordable healthcare is desired by all peoples of the world despite their political, religious, cultural, and philosophical differences. Many Trump voters still rely on his electoral promise of providing such healthcare and lowering drug prices. If he truly does intend to keep this promise, this meeting wasn’t a good way to start.

• Bio
• Latest Posts

Paul Anthony Taylor

Executive Director of the Dr. Rath Health Foundation and one of the coauthors of our explosive book, “The Nazi Roots of the ‘Brussels EU'”, Paul is also our expert on the Codex Alimentarius Commission and has had eye-witness experience, as an official observer delegate, at its meetings.

Prior to joining the Foundation, Paul's background was in the music industry, where he worked as a keyboard player and programmer with artists including Paul McCartney, Bryan Ferry, Bill Withers, the Verve, Texas, and Primal Scream.

He first became interested in natural health after falling ill with a chronic fatigue syndrome-related disorder in 1991 and subsequently making a full recovery through the use of natural health therapies. After meeting Dr. Rath and Dr. Niedzwiecki at an anti-Codex rally in Berlin in 2002, Paul was inspired to make a life-changing decision to leave the music industry to work for the Foundation and help defend the right of patients worldwide to have free access to natural health approaches.

You can find Paul on Twitter at @paulanthtaylor

Der Executive Director der Dr. Rath Health Foundation ist einer der Koautoren des explosiven Buchs „Die Nazi-Wurzeln der Brüsseler EU“. Paul ist auch unser Experte zum Thema „Codex Alimentarius-Kommission“ und hat Augenzeugenerfahrung als offizieller beobachtender Teilnehmer bei diesen Treffen.

Bevor er seine Arbeit bei der Stiftung antrat war Paul in der Musikindustrie aktiv. Er arbeitete als Keyboard-Spieler und Programmierer mit Künstlern wie Paul McCartney, Bryan Ferry, Bill Withers, the Verve, Texas und Primal Scream.

Sein Interesse an natürlicher Gesundheit wuchs, als er 1991 an Störungen erkrankte, die aus einem chronischen Erschöpfungssyndrom resultierten. Durch natürliche Gesundheitstherapien wurde er schließlich vollständig geheilt. Ein Treffen 2002 mit Dr. Rath und Dr. Niedzwiecki bei einer Anti-Codex-Demonstration in Berlin inspirierte ihn zu einer lebensverändernden Entscheidung und er verließ die Musikindustrie um für die Stiftung zu arbeiten und das Recht der Patienten zu verteidigen, weltweit freien Zugang zu natürlichen Gesundheitsverfahren zu haben.

Auf Twitter ist Paul unter @paulanthtaylor zu finden.

Latest posts by Paul Anthony Taylor (see all)

• Police Arrest 22 Suspects During Probe Into Major Fraud Linked to European Union COVID-19 Recovery Fund - April 19, 2024
• Plummeting Deaths From Heart Disease in United States Reflect Rise in Use of Dietary Supplements - April 12, 2024
• Growing Evidence of the Protective Effect of Vitamin D Against Breast Cancer - April 5, 2024
• Doctors Report Mysterious Worldwide Cancer ‘Epidemic’ - March 29, 2024
• ‘Definitive’ Evidence Linking Vitamin D to Lower Risk of COVID-19 and ICU Admission - March 22, 2024